Neuroreport · 2007 · 67 citations · 24 references
MedicineNeurologyNeuroscienceClinical NeuroscienceMovement DisordersNeurodegenerationDopaminergic PharmacologyNeurodegenerative DiseasesParkinson DiseaseParkinsonian DisordersDisease DurationDopamine-related Movement DisordersDopaminergic NeuronsNigrostriatal Dopamine PathwayNigrostriatal Dopamine SystemParkinson Disease ImagingParkinsonian TremorStriatal Dopamine Function
We performed [123I]FP-CIT/SPECT in 20 drug-naive Parkinson's disease (PD) patients, 10 with unilateral akinesia/rigidity at onset (arPD) and 10 with additional tremor-at-rest (tPD), to evaluate whether resting tremor at onset is associated with differences in striatal dopamine transporter binding. Patients of the two cohorts were matched for age, disease duration (<3 years) and severity of non-tremor motor symptoms; 31 healthy participants served as controls. Mean striatal dopamine transporter binding reduction in PD patients vs. controls was 42% for arPD and 50% for tPD; mean ipsilateral striatum and caudate nucleus uptake values were lower by 12 and 24%, respectively, in tPD than arPD. We conclude that widespread degeneration of the nigrostriatal dopaminergic pathway might be necessary for the development of parkinsonian tremor-at-rest.
24
Design and construction of a realistic digital brain phantom
D. Louis Collins, Alex Zijdenbos, Vasken Kollokian et al. · IEEE Transactions on Medical Imaging · 1998 · 1.8K citations
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Andrew Hughes, S. E. Daniel, Samuel Blankson et al. · Archives of Neurology · 1993 · 959 citations